+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine"

From
Microarray Scanners - Global Strategic Business Report - Product Thumbnail Image

Microarray Scanners - Global Strategic Business Report

  • Report
  • October 2025
  • 385 Pages
  • Global
From
Serum-Free Media - Global Strategic Business Report - Product Thumbnail Image

Serum-Free Media - Global Strategic Business Report

  • Report
  • October 2025
  • 476 Pages
  • Global
From
Small-Scale Bioreactors - Global Strategic Business Report - Product Thumbnail Image

Small-Scale Bioreactors - Global Strategic Business Report

  • Report
  • October 2025
  • 141 Pages
  • Global
From
Spatial OMICS - Global Strategic Business Report - Product Thumbnail Image

Spatial OMICS - Global Strategic Business Report

  • Report
  • October 2025
  • 228 Pages
  • Global
From
Omics Lab Services - Global Strategic Business Report - Product Thumbnail Image

Omics Lab Services - Global Strategic Business Report

  • Report
  • October 2025
  • 594 Pages
  • Global
From
From
Microbial API - Global Strategic Business Report - Product Thumbnail Image

Microbial API - Global Strategic Business Report

  • Report
  • October 2025
  • 466 Pages
  • Global
From
Medical Biomimetics - Global Strategic Business Report - Product Thumbnail Image

Medical Biomimetics - Global Strategic Business Report

  • Report
  • October 2025
  • 282 Pages
  • Global
From
Pharmacogenomics Technology - Global Strategic Business Report - Product Thumbnail Image

Pharmacogenomics Technology - Global Strategic Business Report

  • Report
  • October 2025
  • 291 Pages
  • Global
From
Long Read Sequencing - Global Strategic Business Report - Product Thumbnail Image

Long Read Sequencing - Global Strategic Business Report

  • Report
  • October 2025
  • 579 Pages
  • Global
From
From
Bioprocess Monitoring - Global Strategic Business Report - Product Thumbnail Image

Bioprocess Monitoring - Global Strategic Business Report

  • Report
  • October 2025
  • 170 Pages
  • Global
From
From
Cell Culture Vessels - Global Strategic Business Report - Product Thumbnail Image

Cell Culture Vessels - Global Strategic Business Report

  • Report
  • October 2025
  • 387 Pages
  • Global
From
Cell Culture Media - Global Strategic Business Report - Product Thumbnail Image

Cell Culture Media - Global Strategic Business Report

  • Report
  • October 2025
  • 673 Pages
  • Global
From
CRISPR-based Gene Editing - Global Strategic Business Report - Product Thumbnail Image

CRISPR-based Gene Editing - Global Strategic Business Report

  • Report
  • October 2025
  • 172 Pages
  • Global
From
From
CRISPR and Cas Genes - Global Strategic Business Report - Product Thumbnail Image

CRISPR and Cas Genes - Global Strategic Business Report

  • Report
  • October 2025
  • 174 Pages
  • Global
From
gRNA - Global Strategic Business Report - Product Thumbnail Image

gRNA - Global Strategic Business Report

  • Report
  • October 2025
  • 475 Pages
  • Global
From
Loading Indicator

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more